Research Area:  Internet of Things

Abstract:

The current standard testing method for screening coronavirus disease 2019 (COVID-19) is through reverse real-time PCR assay (rRT-PCR), a common molecular-based assay that requires an average of four to six hours to provide results. Although this tool is widely used, it relies on a well-equipped laboratory, trained specialists, and is time-consuming. This limits the number of tests that can be performed. As the COVID-19 outbreak becomes less and less controllable, millions of lives have been threatened, resulting in breakdown of medical systems and considerable worldwide panic. It seems quite clear that rRT-PCR based testing is not useful in the control of the disease epidemic due to the high rate of asymptomatic cases: recent data on a small sample (n = 60) of healthy blood donors in Castiglione D’Adda (epicenter area of Italy), indicated that over 70% of cases had SARS-CoV-2 antibodies [1]. Provision of a suitable COVID-19 diagnostic platform could save lives and alleviate the pressure on front-line healthcare workers and healthcare systems.

Keywords:  

Author(s) Name:  Ting Yang,Mattia Gentile ,Ching-Fen Shen and Chao-Min Cheng

Publisher name:  MDPI

DOI:  10.3390/diagnostics10040224

Volume Information:  Volume 10 Issue 4

Paper Link:   https://www.mdpi.com/2075-4418/10/4/224/htm